Age as the main prognostic factor in adult aggressive non-Hodgkin's lymphoma
- 1 December 1987
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 83 (6) , 1075-1079
- https://doi.org/10.1016/0002-9343(87)90944-2
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Identification of Major Prognostic Subgroups of Patients with Large-Cell Lymphoma Treated with m-BACOD or M-BACODAnnals of Internal Medicine, 1986
- MACOP-B Chemotherapy for the Treatment of Diffuse Large-Cell LymphomaAnnals of Internal Medicine, 1985
- Aggressive Chemotherapy for Diffuse Histiocytic Lymphoma in the Elderly: Increased Complications with Advancing AgeJournal of the American Geriatrics Society, 1984
- Diffuse Aggressive Lymphomas: Increased Survival After Alternating Flexible Sequences of ProMACE and MOPP ChemotherapyAnnals of Internal Medicine, 1983
- Predicting therapeutic outcome in patients with diffuse histiocytic lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP)Cancer, 1982
- Treatment of advanced diffuse histiocytic lymphoma: An analysis of prognostic variablesCancer, 1982
- Factors predicting long-term survival in diffuse mixed, histiocytic, or undifferentiated lymphomaBlood, 1981
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Sequential Nonsurgical and Surgical Staging of Non-Hodgkin's LymphomaAnnals of Internal Medicine, 1976
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958